Marwan Noel Sabbagh
Director/Board Member presso CERVOMED INC.
Profilo
Marwan Noel Sabbagh is a professional with current positions as Non-Executive Director at EIP Pharma, Inc. and Director at CervoMed, Inc. He previously served as an Independent Director at Quince Therapeutics, Inc. and held director positions at Cleveland Clinic Lou Ruvo Center For Brain Health and Banner Sun Health Research Institute.
Sabbagh holds a doctorate degree from the University of Arizona and an undergraduate degree from the University of California, Berkeley.
Posizioni attive di Marwan Noel Sabbagh
| Società | Posizione | Inizio |
|---|---|---|
| CERVOMED INC. | Director/Board Member | 16/08/2023 |
EIP Pharma, Inc.
 EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA. | Director/Board Member | 04/11/2021 |
Precedenti posizioni note di Marwan Noel Sabbagh
| Società | Posizione | Fine |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Director/Board Member | 30/09/2022 |
| Banner Sun Health Research Institute | Director/Board Member | - |
| Cleveland Clinic Lou Ruvo Center For Brain Health | Director/Board Member | - |
Formazione di Marwan Noel Sabbagh
| University of Arizona | Doctorate Degree |
| University of California, Berkeley | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| QUINCE THERAPEUTICS, INC. | Health Technology |
| CERVOMED INC. | Commercial Services |
| Aziende private | 3 |
|---|---|
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA. | Health Technology |
| Cleveland Clinic Lou Ruvo Center For Brain Health | |
| Banner Sun Health Research Institute |
- Borsa valori
- Insiders
- Marwan Noel Sabbagh
